127 related articles for article (PubMed ID: 3954966)
1. Complete remission in plasma cell leukaemia.
Montecucco C; Riccardi A; Merlini G; Ascari E
Br J Haematol; 1986 Mar; 62(3):525-7. PubMed ID: 3954966
[TBL] [Abstract][Full Text] [Related]
2. Complete remission in plasma cell leukaemia.
Krsnik I; Peñalver MA; Del Potro E; Diaz-Mediavilla J
Br J Haematol; 1987 May; 66(1):145. PubMed ID: 3593651
[No Abstract] [Full Text] [Related]
3. [Complete double remission and prolonged survival of a patient diagnosed with plasma cell leukemia].
Sureda A; Pérez de Oteyza J; García Laraña J; Odriozola J
Sangre (Barc); 1989 Jun; 34(3):244. PubMed ID: 2762986
[No Abstract] [Full Text] [Related]
4. A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol).
Ferrara F; Del Vecchio L; Mele G; Rametta V; Ronconi F; Montuori R
Cancer; 1989 Aug; 64(4):789-92. PubMed ID: 2743271
[TBL] [Abstract][Full Text] [Related]
5. Effective cytotoxic treatment of primary plasma cell leukaemia--a report of 3 cases.
Gangadharan VP; Satishkumar K; Pillai R; Cherian V
Acta Oncol; 1994; 33(6):714-5. PubMed ID: 7946458
[No Abstract] [Full Text] [Related]
6. [Case of plasmacytic leukemia with complete remission and 1-year survival after a combined 5-drug sequence therapy].
Anisimowicz J; Mizan K
Pol Tyg Lek; 1984 Sep; 39(36):1209-10. PubMed ID: 6504747
[No Abstract] [Full Text] [Related]
7. Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myeloma.
Riccardi A; Merlini G; Montecucco C; Danova M; Ucci G; Cassano E; Ascari E
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):787-91. PubMed ID: 3770037
[TBL] [Abstract][Full Text] [Related]
8. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
[TBL] [Abstract][Full Text] [Related]
9. Peptichemio, vincristine, prednisone induction treatment in multiple myeloma.
Merlini G; Riccardi A; Riccardi PG; Montecucco CM; Pavesi F; Ascari E
Tumori; 1985 Dec; 71(6):581-8. PubMed ID: 4082291
[TBL] [Abstract][Full Text] [Related]
10. [Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy].
Shindo T; Yumoto Y; Yoshida M; Okuda T
Rinsho Ketsueki; 2002 Feb; 43(2):107-11. PubMed ID: 11925872
[TBL] [Abstract][Full Text] [Related]
11. IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha.
Yamagata N; Shimazaki C; Goto H; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Nakagawa M
Am J Hematol; 1994 Mar; 45(3):262-4. PubMed ID: 8296801
[TBL] [Abstract][Full Text] [Related]
12. Peptichemio induction therapy in myelomatosis.
Merlini G; Gobbi PG; Riccardi A; Riva G; Sardi C; Perugini S
Cancer Chemother Pharmacol; 1982; 8(1):9-16. PubMed ID: 7094202
[TBL] [Abstract][Full Text] [Related]
13. Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen.
Libby E; Candelaria-Quintana D; Moualla H; Abdul-Jaleel M; Rabinowitz I
Am J Hematol; 2010 Sep; 85(9):733-4. PubMed ID: 20669178
[No Abstract] [Full Text] [Related]
14. [Results with the use of the M-2 protocol in plasmacytoma].
Ho AD; Wittkamp S; Theml H; Keilholz U; Hunstein W
Dtsch Med Wochenschr; 1986 May; 111(22):858-61. PubMed ID: 3754811
[TBL] [Abstract][Full Text] [Related]
15. Primary plasma cell leukaemia. A case report and a review of the literature.
Osanto S; Müller HP; Schuit HR; Van Nieuwkoop JA; Willemze R
Acta Haematol; 1983; 70(2):122-9. PubMed ID: 6408874
[TBL] [Abstract][Full Text] [Related]
16. Survival of twenty-two months in a patient with primary plasma cell leukaemia treated with melphalan and prednisolone.
Walker JD; Kaczmarski RS
Postgrad Med J; 1988 Mar; 64(749):232-5. PubMed ID: 3174543
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell leukemia--report on two cases.
Singh VP; Sundar S; Kumar K; Shukla J; Dube B
J Assoc Physicians India; 1994 Oct; 42(10):824-5. PubMed ID: 7876056
[No Abstract] [Full Text] [Related]
18. [Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper-CVAD and high-dose melphalan followed by autologous peripheral blood stem cell transplantation].
Hosono N; Yamauchi T; Nakamura T; Yamashita T; Ueda T
Gan To Kagaku Ryoho; 2008 Mar; 35(3):533-7. PubMed ID: 18347412
[TBL] [Abstract][Full Text] [Related]
19. [p170 in multiple myeloma and acute leukemia].
Riccardi A; Invernizzi R; Ucci G; Luoni R; Danova M; Giordano M; Zambelli ML; Rastaldi MP; Ascari E
Haematologica; 1991 Jun; 76 Suppl 3():177-80. PubMed ID: 1684345
[No Abstract] [Full Text] [Related]
20. Alternating intravenous courses of melphalan and peptichemio in high-risk multiple myeloma (preliminary results).
Franchi F; Seminara P; Rossi Fanelli F
Anticancer Res; 1986; 6(2):297-8. PubMed ID: 3707066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
